Literature DB >> 11095541

Obsessive-compulsive disorder and comorbid anxiety problems in a national anxiety screening sample.

L A Welkowitz1, E L Struening, J Pittman, M Guardino, J Welkowitz.   

Abstract

Questionnaire data were obtained from 5867 participants attending a national anxiety screening program. These participants were selected from more than 15,000 respondents on the basis of never having received treatment for a mental health problem. A screening instrument was designed to assess five anxiety disorders (obsessive-compulsive disorder, posttraumatic stress disorder, social phobia, generalized anxiety disorder, and panic disorder). The present study focused on those participants meeting full or partial screening criteria for obsessive-compulsive disorder (n = 3212), with those not meeting criteria for obsessive-compulsive disorder (n = 2655) serving as a comparison group. Significant relationships were found between questionnaire scores on both interference with daily living, readiness for treatment, and the number of comorbid anxiety problems. These findings shed light on the extent to which undiagnosed and untreated persons with obsessional or compulsive symptoms, or both, are experiencing, as well as the factors that may lead them to seek formal psychiatric or psychological treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11095541     DOI: 10.1016/s0887-6185(00)00034-7

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  9 in total

Review 1.  [Obsessive-compulsive disorder: psychosocial consequences and quality of life: a review].

Authors:  M Hauschildt; S Moritz
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

2.  Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study.

Authors:  Brook A Marcks; Risa B Weisberg; Ingrid Dyck; Martin B Keller
Journal:  Compr Psychiatry       Date:  2011-02-23       Impact factor: 3.735

3.  Cognitive Training via a Mobile Application to Reduce Obsessive-Compulsive-Related Distress and Cognitions During the COVID-19 Outbreaks: A Randomized Controlled Trial Using a Subclinical Cohort.

Authors:  Burcin Akin-Sari; Mujgan Inozu; A Bikem Haciomeroglu; Banu Cicek Cekci; Elif Uzumcu; Guy Doron
Journal:  Behav Ther       Date:  2022-01-08

4.  Clinical features of muscle dysmorphia among males with body dysmorphic disorder.

Authors:  Courtney G Pope; Harrison G Pope; William Menard; Christina Fay; Roberto Olivardia; Katharine A Phillips
Journal:  Body Image       Date:  2005-12

5.  Axis I comorbidity in body dysmorphic disorder.

Authors:  John Gunstad; Katharine A Phillips
Journal:  Compr Psychiatry       Date:  2003 Jul-Aug       Impact factor: 3.735

Review 6.  Neurobiology of rodent self-grooming and its value for translational neuroscience.

Authors:  Allan V Kalueff; Adam Michael Stewart; Cai Song; Kent C Berridge; Ann M Graybiel; John C Fentress
Journal:  Nat Rev Neurosci       Date:  2015-12-17       Impact factor: 34.870

7.  Greater history of traumatic event exposure and PTSD associated with comorbid body dysmorphic disorder in a large OCD cohort.

Authors:  Jorge Valderrama; Stella Kim Hansen; Carlos Pato; Katharine Phillips; James Knowles; Michele T Pato
Journal:  Psychiatry Res       Date:  2020-05-06       Impact factor: 11.225

8.  Prevalence and correlates of obsessive-compulsive disorder and subthreshold obsessive-compulsive disorder among college students in Kerala, India.

Authors:  T S Jaisoorya; Y C Janardhan Reddy; B Sivasankaran Nair; Anjana Rani; Priya G Menon; M Revamma; C R Jeevan; K S Radhakrishnan; Vineetha Jose; K Thennarasu
Journal:  Indian J Psychiatry       Date:  2017 Jan-Mar       Impact factor: 1.759

9.  Preliminary Analysis of the Factor Structure, Reliability and Validity of an Obsessive-Compulsive Disorder Screening Tool for Use with Adults in Malaysia.

Authors:  Normah Che Din; Liana Mohd Nawi; Shazli Ezzat Ghazali; Mahadir Ahmad; Norhayati Ibrahim; Zaini Said; Noh Amit; Ponnusamy Subramaniam
Journal:  Int J Environ Res Public Health       Date:  2019-11-28       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.